International Study Compares Self-Expanding and Balloon-Expandable Transcatheter Aortic-Valve Replacement in Patients with Small Aortic Annulus
Pittsburgh's Allegheny General Hospital Serves as Landmark Clinical Trial's Top Enrolling Site in the United States PITTSBURGH, April 17, 2024 /PRNewswire-PRWeb/ -- Allegheny Health Network's (AHN) Allegheny General Hospital (AGH) was the top U.S. enrollment site for a landmark... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 17, 2024 Category: Pharmaceuticals Tags: TRI Source Type: news
TAVI Comparable With SAVR in Lower-Risk Aortic Stenosis TAVI Comparable With SAVR in Lower-Risk Aortic Stenosis
The randomized DEDICATE-DZHK6 trial shows transcatheter aortic valve repair measures up to the surgical approach in patients with low-to-intermediate-risk aortic stenosis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 15, 2024 Category: Consumer Health News Tags: Cardiology News Source Type: news
Self-Expanding Evolut Valves Edge Out Sapien in Majority-Female TAVR Trial
(MedPage Today) -- ATLANTA -- For transcatheter aortic valve replacement (TAVR) candidates with a small aortic annulus, the two leading platforms offered differing hemodynamic valve performances despite being similarly effective at 1 year, according... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 8, 2024 Category: Cardiology Source Type: news
Abbott Receives FDA Approval for TriClip ™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve
(Source: Abbott.com)
Source: Abbott.com - April 2, 2024 Category: Pharmaceuticals Source Type: news
The Most Exciting New Advances in Managing COPD
The Global Initiative for Chronic Obstructive Lung Disease, or GOLD, is the world’s preeminent COPD research and advocacy organization. Founded in 1997 in collaboration with the U.S. National Institutes of Health and the World Health Organization, one of GOLD’s stated aims is to “improve prevention and treatment of this lung disease.”
In its 2023 global strategy report, GOLD changed its definition of COPD—which many in the profession viewed as overdue. Specifically, the new definition emphasized the heterogeneity of COPD in terms of its underlying drivers and long-term disease course.
[ti...
Source: TIME: Health - March 18, 2024 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized freelance Source Type: news
Tanzania: BMH Performs Highly-Specialized Artificial Heart Valve Surgery
[Daily News] The Dodoma-based Benjamin Mkapa Hospital (BMH) has successfully managed to perform the highly-specialized artificial heart valve surgery (HVS), making it to become the second health facility in the country to roll out the key life-serving surgery. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 26, 2024 Category: African Health Tags: East Africa Health and Medicine Tanzania Source Type: news
Hospital CEO Died After Surgery, Lawsuit Follows; Doc Sues Over Noncompete
(MedPage Today) -- A hospital CEO died after heart surgery, and now her family is suing the University of Chicago Health System for negligence. Surgeons recommended a heart valve repair using a "minimally invasive robotic procedure," but the family... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - February 22, 2024 Category: American Health Source Type: news
TAVR Pioneer Dies; Allograft Rejection Criteria Need Work; Overeating Protein & CVD
(MedPage Today) -- Alain Cribier, MD, who performed the first transcatheter aortic valve replacement (TAVR) in 2002, died last week at age 79, the American College of Cardiology announced.
Higher lipoprotein(a) went hand in hand with increased... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 20, 2024 Category: Cardiology Source Type: news
Cardiology's Quantum Leap: FDA's Advisory Panel Gives Thumbs Up To Abbott's Minimally Invasive Heart Valve Repair Device
Tuesday, the FDA’s Circulatory System Devices Panel of the Medical Devices Advisory Committee for the FDA confirmed 13 to 1, with 0 abstention, that the benefits of Abbott Laboratories ABT TriClip transcatheter edge-to-edge repair (TEER) system outweighed the risks to treat tricuspid regurgitation…#fda #abbottlaboratories #abttriclip #abbott #triclip #mitraclip #amplatzerpiccolo #navitor #abt (Source: Reuters: Health)
Source: Reuters: Health - February 14, 2024 Category: Consumer Health News Source Type: news
Use of Transcatheter Aortic Valve Replacement Up in Adults Younger Than 60
TUESDAY, Feb. 13, 2024 -- For patients aged younger than 60 years, transcatheter aortic valve replacement (TAVR) is increasingly used and has overtaken surgical aortic valve replacement (SAVR), despite significantly better survival rates for SAVR,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 13, 2024 Category: Pharmaceuticals Source Type: news
Caution Raised for Post-TAVR Cardiac Surgeries
(MedPage Today) -- SAN ANTONIO -- The early experience of patients needing cardiac surgery after transcatheter aortic valve replacement (TAVR) has surgeons raising the alarm about the excess risks of these challenging procedures, based on data... (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - January 29, 2024 Category: Surgery Source Type: news
'Tootsie Roll' Introduced for Leaky Transcatheter Heart Valves
(MedPage Today) -- Operators reported the initial success of a novel transcatheter technique for treating complex paravalvular leaks (PVLs) after transcatheter aortic valve replacement (TAVR) or transcatheter mitral valve replacement (TMVR) in... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - January 19, 2024 Category: Cardiology Source Type: news
Temporary Higher Stroke Rate After TAVR Temporary Higher Stroke Rate After TAVR
The risk for stroke is elevated in patients undergoing transcatheter aortic valve replacement but only for up to 2 years.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - January 11, 2024 Category: Neurology Tags: Cardiology Source Type: news
Warfarin Cuts Mortality, Thromboembolism After Valve Replacement
THURSDAY, Jan. 4, 2024 -- Warfarin use after bioprosthetic surgical aortic valve replacement (sAVR) is associated with lower all-cause mortality and a decreased risk for thromboembolism compared with not receiving warfarin, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 4, 2024 Category: Pharmaceuticals Source Type: news
CardioMech secures $13 million for clinical trial of heart valve device
CardioMech is developing a heart valve repair device that treats degenerative mitral regurgitation, a cardiovascular ailment usually treated by open-heart surgery. It plans to open a clinical trial early next year. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 2, 2024 Category: Pharmaceuticals Authors: Alyxandra Sego Source Type: news
